Agilon Health, Inc. amended its Credit Agreement on February 12, 2026, extending the maturity date to February 18, 2028, and reducing revolving credit commitments from $100 million to $90 million. The Company must maintain at least $50 million in Total Cash and achieve positive EBITDA for two consecutive periods to make certain payments.